Madrid, Spain
Teamer in 6 Groups
Contributes every month: €6 to 6 Groups
Since 04-11-2017 has contributed €426
Teamer since: 04/11/2017
The Benjamín Mehnert Foundation is a non-profit organization committed to the situation of pet animals that suffer abuse or neglect in our country, focusing mainly on the rescue, recovery and relocation of greyhounds in family homes, providing them a new opportunity as pets. Although mainly we are dedicated to the recovery of greyhounds, currently in our refuge live more than 700 animals...
Teamer since: 04/11/2017
Did you know that 5,000 people get sick with leukaemia each year in Spain, which is the most common childhood cancer, and that despite the progress made, we still lose one in four minors and half of adults? At the Josep Carreras Foundation we have been working for more than 30 years to make leukaemia a 100% curable disease, to find 100% compatible donors for everyone, and to make displaced patients feel at home. With your help, we are unstoppable.
Teamer since: 04/11/2017
Hoope is an animal welfare organization that rescues, cares for and seeks homes for abandoned animals. We have two centers in Madrid, a municipal CPA and a sanctuary where various animals live, such as donkeys, horses, dogs, cats, rabbits, goats, pigs, chickens, ducks, sheep ... Likewise, at Hoope we go one step further and carry out projects to help people at risk of social exclusion, because we want to take care of that essential bond that unites us and makes us stronger.
Teamer since: 20/02/2019
Soy Marco y Tay-Sachs ha marcado mi vida ya que mi hijo Liam la padecía. En España hay, en este momento, 13 niños y niñas afectados por las enfermedades de Tay-Sachs y Sandhoff. ACTAYS recauda fondos para financiar la investigación y gracias a personas como tú hemos logrado que 2 universidades estudien Tay-Sachs y Sandhoff. Te necesitamos por todos los niños que padecen estas enfermedades, presentes y futuros. 12 Teamers= 1,5h de investigación.
Teamer since: 20/02/2019
We are an NGO that seeks to improve the quality of life in CF by improving access to treatments that we consider essential for those affected, such as respiratory physiotherapy in the home and new medicines such as Orkambi or Symkevi. It is our obligation to improve the application of treatment and favor the autonomy and independence of children and young people with cystic fibrosis.